Global X Genomics & Biotechnology UCITS ETF (LON:GNOM)

Assets	95.01M
Expense Ratio	0.50%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+80.20%

Volume	8,376
Open	12.23
Previous Close	12.36
Day's Range	12.16 - 12.46
52-Week Low	6.58
52-Week High	12.46
Beta	1.03
Holdings	52
Inception Date	Nov 2, 2021

About GNOM

The Global X Genomics & Biotechnology UCITS ETF (GNOM LN) strives to deliver investment performance that broadly aligns with the price and income generated by the Solactive Genomics v2 Index, prior to the deduction of its fees and expenses.

• Asset Class: Equity
• Category: Theme
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GNOM
• Provider: Global X
• Index Tracked: Solactive Genomics v2 Index - Benchmark TR Net

Performance

GNOM had a total return of 80.20% in the past year, including dividends. Since the fund's inception, the average annual return has been -5.14%.

Top 10 Holdings

52.64% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	7.98%
Twist Bioscience Corporation	TWST	7.39%
10x Genomics, Inc.	TXG	6.53%
Guardant Health, Inc.	GH	5.76%
Illumina, Inc.	ILMN	5.27%
Natera, Inc.	NTRA	5.12%
Genscript Biotech Corporation	1548	4.29%
Bio-Techne Corporation	TECH	3.55%
BioMarin Pharmaceutical Inc.	BMRN	3.40%
Vertex Pharmaceuticals Incorporated	VRTX	3.35%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error